Measurement of Platelet Dense Granule Release in Healthy Volunteers
Status:
Withdrawn
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
Aspirin has been shown to reduce cardiovascular events in at risk individuals. Elucidation of
mechanisms of aspirin resistance and a possible loss of effect of aspirin over time with
chronic aspirin treatment necessitate a more precise method of measuring the "release phase"
of platelet activation, including the release of dense granules from platelets.
Phase:
N/A
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center